Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.27) per share.
Purple Biotech Q3 EPS $(0.27)
Purple Biotech (NASDAQ:PPBT) reported quarterly losses of $(0.27) per share.
Related Posts
‘Second death linked to potential antibody treatment for Alzheimer’s disease’ – science.org
November 28, 8:08 AM
Second death linked to potential antibody treatment for Alzheimer’s disease | Science | AAAS
Cathie Wood Says Bitcoin, Ethereum ‘Didn’t Skip A Beat’ Even As FTX, Celsius Collapsed
February 28, 12:43 AM
Ark Investment Management CEO Cathie Wood defended Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH), saying the two major cryptocurrencies "d
Wedbush Maintains Outperform on Silvergate Capital, Lowers Price Target to $70
November 14, 10:23 AM
Wedbush analyst David Chiaverini maintains Silvergate Capital (NYSE:SI) with a Outperform and lowers the price target from $85 to $70.